Skip to main content
Clinical Trials/NCT04199091
NCT04199091
Completed
Not Applicable

Craniosacral Therapy Versus Progressive Muscle Relaxation as Self-help Strategies for Patients With Chronic Non-specific Back Pain: a Randomized Controlled Trial

Universität Duisburg-Essen1 site in 1 country76 target enrollmentAugust 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Low Back Pain, Mechanical
Sponsor
Universität Duisburg-Essen
Enrollment
76
Locations
1
Primary Endpoint
Functional Impairment
Status
Completed
Last Updated
5 months ago

Overview

Brief Summary

Craniosacral Therapy (CST) is a non-manipulative, very gentle manual treatment method. Although the mechanisms of action have not yet been investigated sufficiently, initial clinical trials support CST efficacy/effectiveness in chronic pain disorders such as back pain, neck pain, and fibromyalgia. In clinical practice, therapists also report pain alleviating effects of CST self-help techniques, offered to patients within a group concept. Yet, the effectiveness of teaching CST self-help techniques to medical laypersons has not yet been scientifically investigated.

Therefore, this study aims at collecting quantifiable data on the effectiveness and safety of a CST self-help group concept, developed for patients with chronic non-specific low back pain. The intervention group will receive 24 lessons of education and practice in CST self-help techniques over 12 weeks, while the control group will receive the same amount of self-help (education and practice) in progressive muscle relaxation. Six and 12 months after randomization, longer-term effects will be investigated.

Registry
clinicaltrials.gov
Start Date
August 1, 2023
End Date
September 29, 2025
Last Updated
5 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Heidemarie Haller

Principal Investigator

Universität Duisburg-Essen

Eligibility Criteria

Inclusion Criteria

  • Chronic non-specific / functional lower back pain for at least 3 months
  • Functional impairment: minimal 11 and maximal 41 points on the ODI
  • Willingness to participate in the group program and practice at home

Exclusion Criteria

  • Specific back pain due to:
  • Severe congenital or acute degenerative diseases
  • Severe inflammatory musculoskeletal or rheumatic diseases
  • Neurological diseases
  • Status after actue trauma/whiplash
  • Status after neoplasms in the area of the spinal column
  • Acute severe comorbid mental illness or other acute severe comorbid somatic illness
  • Pregnancy
  • Current pension application
  • Regular use of corticosteroids, opiates, muscle relaxants, or antidepressants

Outcomes

Primary Outcomes

Functional Impairment

Time Frame: Week 12

Oswestry Disability Index (ODI): Self-report scale from 0 to 50 points with higher scores indicate higher functional impairment.

Secondary Outcomes

  • Severity of Depressive Symptoms(Week 52)
  • Severity of Anxious Symptoms(Week 52)
  • Total Number (and Type) of Adverse Events(Week 12)
  • Health-related Quality of Life(Week 52)
  • Global Improvement(Week 52)
  • Functional Impairment(Week 52)
  • Pain Intensity(Week 52)
  • Number of Patients with Adverse Events(Week 12)

Study Sites (1)

Loading locations...

Similar Trials